Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Documented diagnosis of IPF.~* Receiving supplemental oxygen for use at rest.~* Weight ≥ 40 kg.~* Male or female of child bearing potential willing and able to use highly effective methods of contraception from study start to 30 days after the last dose of study drug.~Exclusion Criteria:~* FEV1/FVC \< 70%~* History of other interstitial lung diseases.~* Subject plans to begin or has commenced pulmonary rehabilitation within 30 days of screening.~* Corticosteroid (\> 10 mg per day of prednisone or an equivalent) administered for 7 days or longer, within 30 days of screening.~* Participated in another clinical trial of an investigational drug (or medical device) within 30 days or 5-half-lives, whichever is longer, prior to screening, or is currently participating in another trial of an investigational drug (or medical device).~* Female who is breast-feeding or pregnant~* Current smoker or history of smoking within 3 months from screening

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- GBT440 900 mg Dose (Type: EXPERIMENTAL): Part A, 900 mg~GBT440: Capsules which contain GBT440 drug substance in Swedish orange
- GBT440 1500 mg Dose (Type: EXPERIMENTAL): Part B , 1500 mg~GBT440: Capsules which contain GBT440 drug substance in Swedish orange

Based on this trial design, predict the completion outcome and termination type (if applicable).